Opportunity Information: Apply for CDC RFA PS09 992
Apply for CDC RFA PS09 992
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Provision of Integrated HIV Prevention Interventions, including Voluntary Medical Male Circumcision (VMMC) in Nyanza Province, in the Republic of Kenya, under the President s Emergency Plan for AIDS Relief" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on May 7, 2009 and posted on Apr 14, 2009.
- Applicants must submit their applications by Jun 15, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $3,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $3,500,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity is a CDC cooperative agreement issued under the President's Emergency Plan for AIDS Relief (PEPFAR) to support integrated HIV prevention services in Nyanza Province, Kenya, with a specific emphasis that includes Voluntary Medical Male Circumcision (VMMC). The announcement is identified as CDC RFA PS09-992 and is categorized as a discretionary health funding opportunity under CFDA 93.067 (Global AIDS). The overall intent is to expand and strengthen evidence-based HIV prevention in a high-burden area by using a "highly active combination HIV prevention" approach, meaning multiple proven prevention interventions are delivered together in a coordinated way rather than as isolated activities.
The CDC anticipated making about one award with an estimated total funding amount of approximately $3,500,000. The award ceiling is listed at $3,500,000 and the award floor at $1,000,000, signaling that CDC expected one major implementer (or a lead organization with partners) capable of operating at scale. The funding instrument type is a cooperative agreement, which typically indicates a more substantial level of involvement by CDC compared to a standard grant, such as collaboration on program strategy, monitoring, evaluation, and alignment with PEPFAR and national HIV priorities. There is no cost-sharing or matching requirement stated for applicants.
From a programmatic standpoint, the purpose is to strengthen broad, evidence-based HIV prevention interventions in Nyanza Province, with VMMC explicitly included as part of the integrated package. In the PEPFAR context around this period, combination prevention generally implied linking biomedical interventions (like VMMC) with behavioral and structural components, potentially including risk-reduction counseling, HIV testing and counseling, condom promotion and distribution, STI services, referral pathways to HIV care and treatment, and community outreach to generate demand and improve uptake. The framing suggests the awardee would be expected to implement services in a coordinated manner that maximizes population-level impact and supports sustained delivery through local systems. Even though the brief summary does not list specific performance targets, combination prevention language strongly implies that the project would need to demonstrate measurable outputs (for example, numbers of circumcisions performed, clients reached with prevention services, or referrals completed) and track outcomes consistent with CDC and PEPFAR reporting expectations.
Eligibility for the opportunity is described as unrestricted, meaning it was open to any type of entity as long as it met the criteria and any additional eligibility clarifications included in the full text of the announcement. The opportunity was posted on April 14, 2009, with an original closing date of May 29, 2009, later extended to a current closing date of June 15, 2009. The expected funding date was prior to September 30, 2009, aligning with the U.S. federal fiscal year timeline. The notice also clarifies that while the opportunity title appears on the CDC funding opportunities page, applicants were expected to use the full announcement on Grants.gov for complete requirements, application instructions, and program details.
For access or technical issues obtaining the full announcement, the listed point of contact is the CDC Procurement and Grants Office (PGO), with a phone number provided (770-488-2700). Overall, this opportunity reflects a focused, single-award investment intended to scale integrated, evidence-based HIV prevention services in Nyanza Province, using VMMC as a central biomedical component within a broader combination prevention strategy under PEPFAR.
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This is a CDC cooperative agreement funding opportunity issued under the President's Emergency Plan for AIDS Relief (PEPFAR) to support integrated, evidence-based HIV prevention services in Nyanza Province, Kenya. The opportunity specifically includes Voluntary Medical Male Circumcision (VMMC) as part of the prevention package.
What is the funding announcement number and program listing?
The announcement is identified as CDC RFA PS09-992. It is categorized under CFDA 93.067 (Global AIDS) as a discretionary health funding opportunity.
Where will the project activities take place?
The focus area described is Nyanza Province, Kenya, which is presented as a high-burden area for HIV where integrated prevention services are intended to be expanded and strengthened.
What is the main purpose of the award?
The purpose is to expand and strengthen broad, evidence-based HIV prevention interventions in Nyanza Province using a "highly active combination HIV prevention" approach, with VMMC explicitly included as part of the integrated package.
What does "highly active combination HIV prevention" mean in this announcement?
It means delivering multiple proven HIV prevention interventions together in a coordinated way rather than offering them as isolated activities. The summary frames this as an integrated approach intended to maximize population-level impact.
Is VMMC required or optional within the proposed program?
VMMC is explicitly included as part of the integrated prevention package described in the opportunity, indicating it is a specific emphasis area within the broader combination prevention strategy.
What other types of prevention activities are implied by the combination prevention approach?
While the summary does not list a mandatory service menu, it indicates that combination prevention in the PEPFAR context typically links biomedical interventions (such as VMMC) with behavioral and structural components. Examples mentioned include risk-reduction counseling, HIV testing and counseling, condom promotion and distribution, STI services, referral pathways to HIV care and treatment, and community outreach to generate demand and improve uptake.
How much funding is available under this opportunity?
The CDC anticipated an estimated total funding amount of approximately $3,500,000.
How many awards did CDC expect to make?
CDC anticipated making about one award, suggesting a single major implementer (or a lead organization with partners) capable of operating at scale.
What are the minimum and maximum award amounts?
The award ceiling is $3,500,000 and the award floor is $1,000,000.
What type of funding mechanism is used?
The instrument type is a cooperative agreement.
What does it mean that this is a cooperative agreement rather than a standard grant?
The summary indicates that a cooperative agreement typically includes more substantial CDC involvement than a standard grant, such as collaboration on program strategy, monitoring, evaluation, and alignment with PEPFAR and national HIV priorities.
Is cost-sharing or matching required?
No cost-sharing or matching requirement is stated for applicants in the summary provided.
Who is eligible to apply?
Eligibility is described as unrestricted, meaning the opportunity was open to any type of entity as long as it met the criteria and any additional eligibility clarifications included in the full announcement.
Where should applicants look for the complete requirements and instructions?
Applicants were expected to use the full announcement on Grants.gov for complete requirements, application instructions, and program details. The summary notes that the title appears on the CDC funding opportunities page, but the full text on Grants.gov is the authoritative source for requirements.
When was the opportunity posted?
The opportunity was posted on April 14, 2009.
What was the application deadline?
The original closing date was May 29, 2009, and it was later extended to a current closing date of June 15, 2009.
When was funding expected to be awarded?
The expected funding date was prior to September 30, 2009, aligning with the U.S. federal fiscal year timeline described in the summary.
Are there specific performance targets or deliverables stated in the summary?
The brief summary does not list specific performance targets. However, it indicates that the combination prevention framing strongly implies the need to demonstrate measurable outputs (such as numbers of circumcisions performed, clients reached with prevention services, or referrals completed) and to track outcomes consistent with CDC and PEPFAR reporting expectations.
What kinds of results or reporting expectations are implied?
The summary suggests the project would be expected to track measurable outputs and outcomes aligned with CDC and PEPFAR reporting norms, and to operate in a way that supports sustained delivery through local systems.
What does the opportunity suggest about scale and implementation capacity?
With an anticipated single award and a ceiling of $3,500,000, the summary signals CDC expected one major implementer (or a lead organization with partners) capable of operating at scale in Nyanza Province and delivering coordinated prevention services.
Who should be contacted for access or technical issues obtaining the full announcement?
For access or technical issues obtaining the full announcement, the listed point of contact is the CDC Procurement and Grants Office (PGO) at 770-488-2700.
Browse more opportunities from the same category: Health
Next opportunity: Support the Implementation and Expansion of High Quality HIV Prevention, Care and Treatment Activities at Facility and Community Level in the Eastern and Kibera Slums of Nairobi, Coptic Hospital affiliated Sites and Bomu Clinic affiliated Sites in th
Previous opportunity: Increasing the Capacity of the Government of Barbados to Expand Coordinated HIV Prevention and Strategic Information Programs in Barbados under the President s Emergency Plan for AIDS Relief
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS09 992
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS09 992) also looked into and applied for these:
| Funding Opportunity |
|---|
| Support the Implementation and Expansion of High Quality HIV Prevention, Care and Treatment Activities at Facility and Community Level in the Eastern and Kibera Slums of Nairobi, Coptic Hospital affiliated Sites and Bomu Clinic affiliated Sites in th Apply for CDC RFA PS09 991 Funding Number: CDC RFA PS09 991 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $40,500,000 |
| Technical Assistance to United Nations Children s Fund (UNICEF) to Support the Emergency Plan in the Implementation and Evaluation of HIV/AIDS Prevention, Care, Treatment, and Support Activities for Mothers, Children, and Families under the President Apply for CDC RFA PS09 961 Funding Number: CDC RFA PS09 961 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Microbicide Innovation Program (MIP V) (R21/R33) Apply for RFA AI 09 021 Funding Number: RFA AI 09 021 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Evidence based Approaches to War Related Injuries and Humanitarian Public Health Apply for CDC RFA EH09 904 Funding Number: CDC RFA EH09 904 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| RFI Avian and Pandemic Influenza and Zoonotic Disease Program PREDICT Apply for USAID M OAA GH HSR 09 877 Funding Number: USAID M OAA GH HSR 09 877 Agency: Agency for International Development Category: Health Funding Amount: $75,000,000 |
| RFI Avian and Pandemic Influenza and Zoonotic Disease Program RESPOND Apply for USAID M OAA GH HSR 09 878 Funding Number: USAID M OAA GH HSR 09 878 Agency: Agency for International Development Category: Health Funding Amount: $185,000,000 |
| Improving the Capacity of Panel Physicians Performing Overseas Medical Assessments of U.S. Bound Immigrants and Refugees Apply for CDC RFA CI09 901 Funding Number: CDC RFA CI09 901 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Population based Surveillance for Hemoglobinopathies Apply for CDC RFA DD09 909 Funding Number: CDC RFA DD09 909 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $750,000 |
| Health Professions Recruitment Program for Indians American Indians Into Psychology Apply for HHS 2009 IHS INPSY 0001 Funding Number: HHS 2009 IHS INPSY 0001 Agency: Indian Health Service Category: Health Funding Amount: $250,000 |
| NIAMS Clinical Trial Outcomes Instrument Development Grant Program (U01) Apply for RFA AR 10 005 Funding Number: RFA AR 10 005 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Strengthening Graduate Public Health Training in the Republic of Mozambique under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS09 942 Funding Number: CDC RFA PS09 942 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $150,000 |
| Strengthening the Delivery and Quality of Sexually Transmitted Infections (STI) Prevention and Control Programs through Enhanced Laboratory Based STI Surveillance, Case Management and Program Evaluations in the Republic of South Africa Apply for CDC RFA PS09 9130 Funding Number: CDC RFA PS09 9130 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Renal Function and Chronic Kidney Disease in Aging (R21) Apply for PA 09 166 Funding Number: PA 09 166 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Violence Against Women National On Line Resource Center and E Learning Community of Practice Apply for CDC RFA CE09 905 Funding Number: CDC RFA CE09 905 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $730,000 |
| MCH Autism Intervention Research Apply for HRSA 09 217 Funding Number: HRSA 09 217 Agency: Health Resources and Services Administration Category: Health Funding Amount: $400,000 |
| State Health Access Program (SHAP) Apply for HRSA 09 226 Funding Number: HRSA 09 226 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Improving Access to High Quality Comprehensive HIV related Services in Malawi through the Malawi Ministry of Health under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 967 Funding Number: CDC RFA PS09 967 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Human Immunodeficiency Virus (HIV) and Sexually Transmitted Diseases (STD) Partner Services Technical Assistance for Health Departments and their Grantees through Capacity Building Assistance Providers (CBA) Apply for CDC RFA PS09 9105 Funding Number: CDC RFA PS09 9105 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Outcome Monitoring of Mpowerment Delivered by Community Based Organizations Funded to Conduct HIV Prevention through CDC Funding Opportunity Announcement PS06 618 Apply for CDC RFA PS09 947 Funding Number: CDC RFA PS09 947 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Rapid Assessment Post Impact of Disaster (R03) Apply for PAR 09 171 Funding Number: PAR 09 171 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS09 992", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.